121 studies found for:    aspirin | United States, New York | Studies with Male Participants
Show Display Options
Rank Status Study
21 Completed XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Conditions: Chronic Total Occlusion of Coronary Artery;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Intervention: Drug: DAPT
22 Active, not recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
23 Recruiting Antiplatelet Therapy in HIV
Conditions: HIV;   Cardiovascular Diseases;   Inflammation
Interventions: Drug: Aspirin;   Drug: Clopidogrel
24 Active, not recruiting
Has Results
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Acetylsalicylic acid
25 Active, not recruiting A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
26 Completed Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
Conditions: Common Cold;   Pharyngitis
Interventions: Drug: Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine;   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Pseudoephedrine;   Drug: Placebo
27 Recruiting Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: Dabigatran Etexilate 110mg;   Drug: Warfarin 3mg;   Drug: Aspirin;   Drug: Dabigatran Etexilate 150mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 5mg;   Drug: Warfarin 1mg
28 Recruiting Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Hydroxyurea;   Drug: Aspirin
29 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
30 Completed
Has Results
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
31 Unknown 
Has Results
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Coronary Stent System;   Device: PROMUS Element Coronary Stent System;   Drug: Aspirin;   Drug: Thienopyridine
32 Completed
Has Results
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Condition: Stroke
Interventions: Drug: Aggrenox;   Drug: Clopidogrel placebo;   Drug: Micardis;   Drug: Aggrenox placebo;   Drug: Clopidogrel;   Drug: Micardis placebo
33 Active, not recruiting PROMUS Element Plus US Post-Approval Study
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Plus Coronary Stent System;   Drug: Aspirin;   Drug: P2Y12 antagonist
34 Recruiting Etanercept in Kawasaki Disease
Conditions: Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions: Drug: Etanercept;   Drug: Placebo
35 Recruiting Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
Condition: Transcatheter Aortic Valve Replacement
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
36 Completed
Has Results
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
Condition: Increased Drug Resistance
Interventions: Drug: Aspirin;   Drug: Lovaza;   Drug: Both Aspirin and Lovaza;   Other: Placebo
37 Active, not recruiting
Has Results
Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
Condition: Asthma, Aspirin-induced
Intervention:
38 Recruiting Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
Conditions: Peripheral Artery Disease;   Type 2 Diabetes
Interventions: Drug: Aspirin;   Drug: Ticagrelor;   Drug: Aspirin Placebo;   Drug: Ticagrelor Placebo
39 Completed Fish Oil and Aspirin With Type 2 Diabetes
Condition: Cardiovascular Disease
Intervention: Dietary Supplement: Fish Oil and Aspirin
40 Completed Warfarin Versus Aspirin Recurrent Stroke Study
Condition: Stroke
Interventions: Drug: Active Aspirin;   Drug: Active Warfarin;   Drug: Aspirin placebo;   Drug: Warfarin placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years